Recent Press Releases

GSK and Theravance announce positive results from studies comparing ANORO™ ELLIPTA™ with SERETIDE® DISKUS®and ADVAIR® DISKUS® in patients with COPD

GSK and Theravance announce positive results from studies comparing ANORO™ ELLIPTA™ with SERETIDE® DISKUS®and ADVAIR® DISKUS® in patients with COPD GlaxoSmithKline plc...

Idenix Pharmaceuticals Files Patent Infringement Lawsuits Against Gilead Sciences in Europe

Idenix Pharmaceuticals Files Patent Infringement Lawsuits Against Gilead Sciences in Europe Granted European Patent Covering 2'-Methyl-2'-Fluoro Nucleosides for Treating Hepatitis C Virus...

ISAPS-LEAP Surgical Relief Teams© Respond To Syrian Refugee Crisis

The International Society of Aesthetic Plastic Surgery and the LEAP Foundation Have Deployed 4th Volunteer Team to Amman, Jordan for Week-Long Surgical Mission

Actelion provides update on Asahi litigation

Actelion provides update on Asahi litigation (Thomson Reuters ONE via COMTEX) -- Actelion Pharmaceuticals Ltd / Actelion provides update on Asahi litigation . Processed and transmitted by NASDAQ OMX...

Novartis Bexsero® meningitis B vaccine receives clinical recommendation for use in infants and adolescents in Australia

Novartis Bexsero® meningitis B vaccine receives clinical recommendation for use in infants and adolescents in Australia Australian recommendation adds to clinical recommendations in the Czech...

FDA Advisory committee unanimously recommends Roche's HPV Test as primary screening tool for detection of women at high risk for cervical cancer

FDA Advisory committee unanimously recommends Roche's HPV Test as primary screening tool for detection of women at high risk for cervical cancer Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today...

Actavis Confirms Favorable Ruling in Generic Celebrex® Patent Suit

Actavis Confirms Favorable Ruling in Generic Celebrex® Patent Suit DUBLIN, March 12, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today confirmed that the United States District Court for the...

Mylan Comments on Favorable Ruling in Generic Celebrex(R) Patent Suit

Mylan Comments on Favorable Ruling in Generic Celebrex(R) Patent Suit PITTSBURGH, March 13, 2014 /PRNewswire/ -- Mylan Inc. (Nasdaq: MYL) today confirmed that the United States District Court for the...

FDA Advisory Committee Unanimously Recommends Roche's HPV Test as Primary Screening Tool for Detection of Women at High Risk for Cervical Cancer

PLEASANTON, Calif., March 12, 2014 /PRNewswire/ -- Roche (SIX: RO, ROG; OTCQX: RHHBY) announced t

Bayer aspires to further sales and earnings growth through 2016

Bayer aspires to further sales and earnings growth through 2016 HealthCare: significant increases in sales and margins, mainly thanks to recently launched pharmaceutical products / CropScience aims...

OncoGenex Pharmaceuticals, Inc. Reports Financial Results for Fourth Quarter and Year End 2013

Conference call to be held on Tuesday, March 11, 2014 at 4:30 p.m.

Ventana and Bayer Extend Collaboration

TUCSON, March 11, 2014 /PRNewswire/ -- Ventana Medical Systems, Inc.

Bayer and Onyx Report Phase 3 Study Results of NEXAVAR® (sorafenib) as Adjuvant Treatment for Patients with Liver Cancer Who Have Undergone Surgery or Local Ablation

Bayer and Onyx Report Phase 3 Study Results of NEXAVAR® (sorafenib) as Adjuvant Treatment for Patients with Liver Cancer Who Have Undergone Surgery or Local Ablation WHIPPANY, N.J., THOUSAND...

Reckitt Benckiser Group PLC Acquisition

Reckitt Benckiser Group PLC Acquisition TIDMRB. RNS Number : 8879B Reckitt Benckiser Group PLC 10 March 2014 Slough, England - March 10, 2014- Reckitt Benckiser Group PLC ("RB") (LSE: RB)...

Latifah Hospital and Bayer HealthCare Organize Endometriosis Awareness Campaign

Latifah Hospital and Bayer HealthCare Organize Endometriosis Awareness Campaign Over 100,000 Women in UAE suffer from Endometriosis Disease Dubai, 10 March 2013 - Given the global increase for the...

Teva Announces Launch of Generic Xeloda® Tablets 150 MG and 500 MG in the United States

Teva Announces Launch of Generic Xeloda® Tablets 150 MG and 500 MG in the United States JERUSALEM--(BUSINESS WIRE)--Mar. 7, 2014-- Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) announces the...

PRAC recommends product information of zolpidem be updated with new advice to minimise the risk of next-morning impaired driving ability and mental alertness

PRAC recommends product information of zolpidem be updated with new advice to minimise the risk of next-morning impaired driving ability and mental alertness The European Medicines Agency's...

Bristol-Myers Squibb to close manufacturing facility in Cruiserath, Co. Ireland

Bristol-Myers Squibb to close manufacturing facility in Cruiserath, Co. Ireland March 6, 2014 -- Bristol-Myers Squibb will close its manufacturing facility in Cruiserath, Co. Dublin by the end of...

Pfizer Initiates Nationwide Voluntary Recall of Two Lots of Pfizer's Effexor XR® 150 Mg Extended-Release Capsules and One Lot of Greenstone's Venlafaxine HCl 150 Mg Extended-Release Capsules Due to the Possible Presence of Tikosyn® Capsules

Recall -- Firm Press Release Pfizer Initiates Nationwide Voluntary Recall of Two Lots of Pfizer's Effexor XR® 150 Mg Extended-Release Capsules and One Lot of Greenstone's Venlafaxine HCl...